Tag: Covaxin
15 Results
-
Centre fast tracks emergency approvals for foreign-produced COVID-19 vaccines
Vaccination is one of the critical pillars of COVID control and management strategy adopted by the Centre. Presently two vaccines i.e. Covaxin by Bharat Biotech International Limited (BBIL) and Covishield by Serum Institute of India (SII), have received Emergency Use Authorization (EUA) from the National Regulator (Drugs Controller General of India).
April 13, 2021 -
Mass vaccination, not a full-lockdown, key to defeat COVID-19 virus: Manish Sisodia
Speaking to journalists on this topic, Manish Sisodia said, “The only way to swiftly break the chain of the COVID-19 virus is to vaccinate people of all ages. Mass vaccination, and not full-lockdown, is the way to defeat this deadly virus.”
April 3, 2021 -
Sambit Patra criticises Opposition over Covaxin
Slamming the leadership of opposition ruled states of Punjab, Chhattisgarh, West Bengal, and Kerala, Patra charged them with continuously finding fault with the efficacy of the vaccine.
March 6, 2021 -
Congress-ruled states not rejecting Covaxin, it’s BJP’s politically motivated propaganda: Punjab CM
Amarinder made it clear that safety restrictions and norms in the state shall continue, while ensuring minimum, if any, loss of livelihood to the citizens of the state.
March 6, 2021 -
Controversy erupts over COVAXIN after pan India rollout of COVID-19 vaccination drive, matter reaches Bombay High Court
Manish Tewari has questioned the procedure of giving the approval of using COVAXIN as he claimed that there is no policy framework to authorise the vaccine for emergency use.
January 16, 2021 -
Medicine as well as rigour needed, avoid rumours: PM Modi
Till now, the central government has procured 1.1 crore 'Covishield' and 55 lakh 'Covaxin' vaccines at a cost of Rs 200 and Rs 206 per dose, respectively.
January 16, 2021 -
Bengal: Covid-19 vaccine dry run across 69 centres
State govt has requested Centre to send 6L vials of vaccine.
January 9, 2021 -
Bharat Biotech head stoutly defends Covaxin efficacy
Denouncing the politics over the vaccine he claimed he was a scientist and not a businessman nor a politician.
January 5, 2021 -
Covaxin can deal with new Covid strains too: Bharat Biotech
The leading vaccine maker is also developing a single-dose nasal vaccine for Covid-19.
December 30, 2020 -
Covaxin vials reach NICED for phase III trials
The Kolkata Municipal Corporation (KMC) has already assured the NICED authorities to cooperate in all aspects for successful trial of Covaxin in the city.
November 26, 2020 -
Phase-3 trial of Covaxin begins at Odisha’s SUM Hospital
In phase three, two doses would be administered to each volunteer 28 days apart but the follow-up period would extend to 12 months to look at its long term and side-effects, he said.
November 20, 2020 -
Durgapur school teacher goes through two trials of Covaxin; feels just fineDurgapur school teacher goes through two trials of Covaxin; feels just fine
The human trial of phases 1 and 2 of the vaccine of Bharat Biotech have earlier received approval from DCGI.The Covaxin has been jointly manufactured by Bharat Biotech and ICMR. The human trial has been conducted in 12 hospitals throughout the country.
August 28, 2020 -
COVAXIN 2nd phase clinical testing in Gauhati Medical College
He said the GMCH would provide all-out support for the second phase clinical testing of COVAXIN, which has already shown successful results in phase-one clinical trials.
August 19, 2020 -
AIIMS gives go-ahead for human clinical trial of COVID-19 vaccine
The trials have so far started in AIIMS, Patna, and some more sites.
July 19, 2020 -
‘As per global norms’: ICMR defends claim of launching vaccine for coronavirus on Independence Day
The premier medical body’s response came after it was questioned about the nearly impossible timeline for getting the vaccine ready for the use.
July 4, 2020